Natural killer cell activity and frequency of killer cell immunoglobulin-like receptors in children with different forms of juvenile idiopathic arthritis

Pediatric Allergy and Immunology

Volumn 24, Issue 7, 2013, Pages 691-696

  Zhou, Juan ^a   Tang, Xuemei ^a   Ding, Yuan ^a   An, Yunfei ^a   Zhao, Xiaodong ^a  

^a CHILDREN S HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Cytokine; Cytotoxicity; Juvenile idiopathic arthritis; Killer cell immunoglobulin like receptor; Natural killer cell

Indexed keywords

GAMMA INTERFERON; GRANZYME B; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; PERFORIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL COUNT; CELL FUNCTION; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; FEMALE; FLOW CYTOMETRY; GENE FREQUENCY; GENOTYPE; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; OLIGONUCLEOTIDE PROBE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCHOOL CHILD;

CYTOKINE; CYTOTOXICITY; JUVENILE IDIOPATHIC ARTHRITIS; KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR; NATURAL KILLER CELL;

ADOLESCENT; ARTHRITIS, JUVENILE; CELL SEPARATION; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; FLOW CYTOMETRY; GENOTYPE; GRANZYMES; HUMANS; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LYMPHOCYTE COUNT; MALE; PERFORIN; RECEPTORS, KIR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84885771863     PISSN: 09056157     EISSN: 13993038     Source Type: Journal    
DOI: 10.1111/pai.12130     Document Type: Article

References (27)

1. Ramanan AV, Grom AA. Does systemic-onset juvenile idiopathic arthritis belong under juvenile idiopathic arthritis? Rheumatology 2005: 44: 1350-3.
2. Villanueva J, Lee S, Giannini EH, et al. Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome. Arthritis Res Ther 2005: 7: R30-7.
3. Grom AA. Natural killer cell dysfunction: a common pathway in systemic-onset juvenile rheumatoid arthritis, macrophage activation syndrome, and hemophagocytic lymphohistiocytosis? Arthritis Rheum 2004: 50: 689-98.
4. Salim PH, Jobim M, Jobim LF, Xavier RM. Autoimmune rheumatic diseases and their association with killer immunoglobulin-like receptor genes. Rev Bras Reumatol 2011: 51: 351-6, 362-4.
5. Majorczyk E, Pawlik A, Luszczek W, et al. Associations of killer cell immunoglobulin-like receptor genes with complications of rheumatoid arthritis. Genes Immun 2007: 8: 678-83.
6. Middleton D, Meenagh A, Wright GD. No association in frequency of KIR receptors in patients with rheumatoid arthritis from Northern Ireland. Tissue Antigens 2007: 69: 577-82.
7. Ramírez-de los santos S, Sánchez-hernández PE, Muñoz-valle JF, et al. Associations of killer cell immunoglobulin-like receptor genes with rheumatoid arthritis. Dis Markers 2012: 33: 201-6.
8. Petty RE, Southwood TR, Manners P, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004: 31: 390-2.
9. Chang L, Gusewitch GA, Chritton DB, Folz JC, Lebeck LK, Nehlsen-cannarella SL. Rapid flow cytometric assay for the assessment of natural killer cell activity. J Immunol Methods 1993: 166: 45-54.
10. Kane KL, Ashton FA, Schmitz JL, Folds JD. Determination of natural killer cell function by flow cytometry. Clin Diagn Lab Immunol 1996: 3: 295-300.
11. Cook MA, Moss PA, Briggs DC. The distribution of 13 killer-cell immunoglobulin-like receptor loci in UK blood donors from three ethnic groups. Eur J Immunogenet 2003: 30: 213-21.
12. Tian Z, Gershwin ME, Zhang C. Regulatory NK cells in autoimmune disease. J Autoimmun 2012: 39: 206-15.
13. Schleinitz N, Vély F, Harlé JR, Vivier E. Natural killer cells in human autoimmune diseases. Immunology 2010: 131: 451-8.
14. Shegarfi H, Naddafi F, Mirshafiey A. Natural killer cells and their role in rheumatoid arthritis: friend or foe? Sci World J 2012: 2012: 491974.
15. Ahern DJ, Brennan FM. The role of Natural Killer cells in the pathogenesis of rheumatoid arthritis: major contributors or essential homeostatic modulators? Immunol Lett 2011: 136: 115-21.
16. Park YW, Kee SJ, Cho YN, et al. Impaired differentiation and cytotoxicity of natural killer cells in systemic lupus erythematosus. Arthritis Rheum 2009: 60: 1753-63.
17. Luci C, Gaudy-marqueste C, Rouzaire P, et al. Peripheral natural killer cells exhibit qualitative and quantitative changes in patients with psoriasis and atopic dermatitis. Br J Dermatol 2012: 166: 789-96.
18. Wulffraat NM, Rijkers GT, Elst E, Brooimans R, Kuis W. Reduced perforin expression in systemic juvenile idiopathic arthritis is restored by autologous stem-cell transplantation. Rheumatology 2003: 42: 375-9.
19. Kim WJ, Kim H, Suk K, Lee WH. Macrophages express granzyme B in the lesion areas of atherosclerosis and rheumatoid arthritis. Immunol Lett 2007: 111: 57-65.
20. Saito S, Murakoshi K, Kotake S, Kamatani N, Tomatsu T. Granzyme B induces apoptosis of chondrocytes with natural killer cell-like cytotoxicity in rheumatoid arthritis. J Rheumatol 2008: 35: 1932-43.
21. Bauer K, Knipper A, Hoang TR, et al. Perforin deficiency attenuates collagen-induced arthritis. Arthritis Res Ther 2005: 7: R877-84.
22. Goldbach-mansky R, Suson S, Wesley R, Hack CE, El-gabalawy HS, Tak PP. Raised granzyme B levels are associated with erosions in patients with early rheumatoid factor positive rheumatoid arthritis. Ann Rheum Dis 2005: 64: 715-21.
23. Otten MH, Prince FH, Anink J, et al. Effectiveness and safety of a second and third biological agent after failing etanercept in juvenile idiopathic arthritis: results from the Dutch National ABC Register. Ann Rheum Dis 2013: 72: 721-7.
24. Klein A, Horneff G. Treatment strategies for juvenile idiopathic arthritis. Expert Opin Pharmacother 2009: 10: 3049-60.
25. Vastert SJ, Van wijk R, D'urbano LE, et al. Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis. Rheumatology 2010: 49: 441-9.
26. Zhang K, Biroschak J, Glass DN, et al. Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis is associated with MUNC13-4 polymorphisms. Arthritis Rheum 2008: 58: 2892-6.
27. Hazen MM, Woodward AL, Hofmann I, et al. Mutations of the hemophagocytic lymphohistiocytosis-associated gene UNC13D in a patient with systemic juvenile idiopathic arthritis. Arthritis Rheum 2008: 58: 567-70.